Both peroxiredoxin 1 (PRDX 1) and peroxiredoxin 3 (PRDX 3) proteins were significant and their overexpression in prostate cancer has been proposed to be linked to cancer initiation and progression [41,68]. Here, PRDX1 is linked to prostate carcinoma.